文献速递白血病

E2A-PBX1作为RUNX1共激活因子驱动前B细胞急性淋巴细胞白血病

E2A-PBX1 functions as a coactivator for RUNX1 in acute lymphoblastic leukemia.
PubMed 文献 · Blood · 2020-01-01

该研究通过无偏基因组分析,在t(1;19)阳性前B ALL细胞中鉴定E2A-PBX1直接靶位点,发现其优先结合RUNX1共占的基因激活元件。E2A-PBX1通过PBX1同源域与RUNX1直接互作,且其增强子结合依赖RUNX1而非DNA结合活性。RUNX1是E2A-PBX1介导靶基因激活和白血病发生所必需,且RUNX1本身也被E2A-PBX1直接激活。

要点

  • E2A-PBX1优先结合RUNX1共占的增强子区域并招募p300、MED1及H3K27ac。
  • E2A-PBX1通过PBX1同源域与RUNX1直接互作,其染色质结合依赖RUNX1。
  • RUNX1是E2A-PBX1介导靶基因激活和细胞转化所必需。

核心结论

  • E2A-PBX1通过与RUNX1直接互作,作为共激活因子协同调控转录组,驱动前B ALL发生。
  • RUNX1本身被E2A-PBX1直接激活,形成多层正反馈调控环路。

研究设计与样本

  • 研究类型为基于细胞与生化分析的机制研究,对象为t(1;19)阳性前B ALL细胞。
  • 采用无偏基因组谱分析(cistrome)、生化互作实验、转录组分析和细胞转化实验。

主要发现

  • 与正常E2A相比,E2A-PBX1优先结合RUNX1共占且富集p300、MED1和H3K27ac的基因位点。
  • E2A-PBX1通过PBX1同源域区域与RUNX1直接互作。
  • E2A-PBX1的增强子结合依赖RUNX1互作,不依赖PBX1同源域内的DNA结合活性。
  • RUNX1对E2A-PBX1介导的靶基因激活和白血病发生至关重要。
  • RUNX1基因位点本身被E2A-PBX1直接激活。

临床怎么用

  • 提示RUNX1是E2A-PBX1阳性ALL的潜在治疗靶点,需进一步临床验证。
  • 为t(1;19)阳性前B ALL的机制分层和靶向干预提供理论依据。

局限性

  • 研究主要基于细胞模型和生化分析,体内动物模型验证未在摘要中详述。
  • 未报告临床样本量、疗效数据或靶向干预的体内实验结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

E2A, a basic helix-loop-helix transcription factor, plays a crucial role in determining tissue-specific cell fate, including differentiation of B-cell lineages. In 5% of childhood acute lymphoblastic leukemia (ALL), the t(1,19) chromosomal translocation specifically targets the E2A gene and produces an oncogenic E2A-PBX1 fusion protein. Although previous studies have shown the oncogenic functions of E2A-PBX1 in cell and animal models, the E2A-PBX1-enforced cistrome, the E2A-PBX1 interactome, and related mechanisms underlying leukemogenesis remain unclear. Here, by unbiased genomic profiling approaches, we identify the direct target sites of E2A-PBX1 in t(1,19)-positive pre-B ALL cells and show that, compared with normal E2A, E2A-PBX1 preferentially binds to a subset of gene loci cobound by RUNX1 and gene-activating machineries (p300, MED1, and H3K27 acetylation). Using biochemical analyses, we further document a direct interaction of E2A-PBX1, through a region spanning the PBX1 homeodomain, with RUNX1. Our results also show that E2A-PBX1 binding to gene enhancers is dependent on the RUNX1 interaction but not the DNA-binding activity harbored within the PBX1 homeodomain of E2A-PBX1. Transcriptome analyses and cell transformation assays further establish a significant RUNX1 requirement for E2A-PBX1-mediated target gene activation and leukemogenesis. Notably, the RUNX1 locus itself is also directly activated by E2A-PBX1, indicating a multilayered interplay between E2A-PBX1 and RUNX1. Collectively, our study provides the first unbiased profiling of the E2A-PBX1 cistrome in pre-B ALL cells and reveals a previously unappreciated pathway in which E2A-PBX1 acts in concert with RUNX1 to enforce transcriptome alterations for the development of pre-B ALL.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Pi WC, Wang J, Shimada M, et al. E2A-PBX1 functions as a coactivator for RUNX1 in acute lymphoblastic leukemia. Blood. 2020. PMID: 32276273. doi:10.1182/blood.2019003312

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。